Literature DB >> 20711880

Effect of the C-terminal domain peptide fragment (65-76) of monocytic chemotactic protein-1 (MCP-1) on the interaction between MCP-1 and heparin.

T L Krasnikova1, P I Nikitin, T I Ksenevich, B G Gorshkov, A V Orlov, M V Sidorova, A A Azmuko, T I Arefieva, E N Mamochkina, E E Efremov, Zh D Bespalova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20711880     DOI： 10.1134/S0012496610040150

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN： 0012-4966


× No keyword cloud information.
  9 in total

1.  Determination of association rate constants by an optical biosensor using initial rate analysis.

Authors:  P R Edwards; R J Leatherbarrow
Journal:  Anal Biochem       Date:  1997-03-01       Impact factor: 3.365

Review 2.  Chemokines.

Authors:  B J Rollins
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

3.  The pan-chemokine inhibitor NR58-3.14.3 abolishes tumour necrosis factor-alpha accumulation and leucocyte recruitment induced by lipopolysaccharide in vivo.

Authors:  J Reckless; L M Tatalick; D J Grainger
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

Review 4.  Regulation of protein function by glycosaminoglycans--as exemplified by chemokines.

Authors:  T M Handel; Z Johnson; S E Crown; E K Lau; A E Proudfoot
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

5.  Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice.

Authors:  Mitsuhisa Koga; Hisashi Kai; Kimiyasu Egami; Toyoaki Murohara; Ayami Ikeda; Suguru Yasuoka; Kensuke Egashira; Toyojiro Matsuishi; Mamiko Kai; Yasufumi Kataoka; Michihiko Kuwano; Tsutomu Imaizumi
Journal:  Biochem Biophys Res Commun       Date:  2007-11-06       Impact factor: 3.575

Review 6.  The specific role of chemokines in atherosclerosis.

Authors:  Vincent Braunersreuther; François Mach; Sabine Steffens
Journal:  Thromb Haemost       Date:  2007-05       Impact factor: 5.249

7.  An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo.

Authors:  Tracy M Handel; Zoë Johnson; David H Rodrigues; Adriana C Dos Santos; Rocco Cirillo; Valeria Muzio; Simona Riva; Matthias Mack; Maud Déruaz; Frédéric Borlat; Pierre-Alain Vitte; Timothy N C Wells; Mauro M Teixeira; Amanda E I Proudfoot
Journal:  J Leukoc Biol       Date:  2008-07-28       Impact factor: 4.962

8.  Inhibition of migration of monocytes and granulocytes in vivo by the peptide corresponding to sequence 65-76 of monocyte chemotactic protein-1 (MCP-1).

Authors:  E I Chazov; T L Krasnikova; Z D Bespalova; N B Kukhtina; M G Melekhov; T I Aref'eva; M V Sidorova; A S Molokoedov; T E Gvozdik; B M Mart'yanov; V V Pozdeev; V B Sergienko; T L Bushueva
Journal:  Dokl Biochem Biophys       Date:  2006 Nov-Dec       Impact factor: 0.788

9.  Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo.

Authors:  Elaine K Lau; Chad D Paavola; Zoë Johnson; Jean-Philippe Gaudry; Elena Geretti; Frédéric Borlat; Andreas J Kungl; Amanda E Proudfoot; Tracy M Handel
Journal:  J Biol Chem       Date:  2004-03-18       Impact factor: 5.157
  9 in total
  1 in total

1.  Synthetic peptide fragment (65-76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting.

Authors:  T I Arefieva; T L Krasnikova; A V Potekhina; N U Ruleva; P I Nikitin; T I Ksenevich; B G Gorshkov; M V Sidorova; Zh D Bespalova; N B Kukhtina; S I Provatorov; E A Noeva; E I Chazov
Journal:  Inflamm Res       Date:  2011-07-10       Impact factor: 4.575
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.